Author

Agnes Jonathan

Observed names: A Jonathan, Agness Jonathan, Jonathan A, Jonathan, Agnes

Institution: Muhimbili University of Health and Allied Sciences

Observed institution: Muhimbili University of Health and Allied Sciences

ORCID: 0000-0001-9928-0732

Observed ORCID: 0000-0001-9928-0732

OpenAlex ID: A5046713381

Barriers and Facilitators of Use of Hydroxyurea among Children with Sickle Cell Disease: Experiences of Stakeholders in Tanzania

2021 · Manase Kilonzi, Hamu J. Mlyuka, et al. · Hemato · 24

PDF

Healthcare Workers’ Knowledge and Resource Availability for Care of Sickle Cell Disease in Dar es Salaam, Tanzania

2022 · Agnes Jonathan, Hilda Tutuba, et al. · Frontiers in Genetics · 23

PDF

The Effects of Sickle Cell Disease on the Quality of Life: A Focus on the Untold Experiences of Parents in Tanzania

2022 · Manase Kilonzi, Dorkasi L. Mwakawanga, et al. · International Journal of Environmental Research and Public Health · 22

PDF

Outcomes of Hydroxyurea Accessed via Various Means and Barriers Affecting Its Usage Among Children with Sickle Cell Anaemia in North-Western Tanzania

2023 · Emmanuela E Ambrose, Benson R Kidenya, et al. · Journal of Blood Medicine · 16

PDF

Nasopharyngeal Carriage and Antibiogram of Pneumococcal and Other Bacterial Pathogens from Children with Sickle Cell Disease in Tanzania

2022 · Ritah F Mutagonda, George Bwire, et al. · Infection and Drug Resistance · 16

PDF

Development of the sickle Pan-African research consortium registry in Tanzania: opportunity to harness data science for sickle cell disease

2023 · Daniel Kandonga, Raphael Zozimus Sangeda, et al. · Frontiers in Hematology · 13

PDF

The efficacy of maternal health education and maternal screening on knowledge and the uptake of infant screening for sickle cell disease in Dar-Es-Salaam, Tanzania; a quasi experimental study

2023 · Hilda J. Tutuba, Agnes Jonathan, et al. · BMC Public Health · 13

PDF

Barriers and Facilitators of Availability of Hydroxyurea for Sickle Cell Disease in Tanzania; A Qualitative Study of Pharmaceutical Manufacturers, Importers, and Regulators

2022 · Hamu J. Mlyuka, Manase Kilonzi, et al. · Healthcare · 12

PDF

Sickle Cell Disease in Africa: SickleInAfrica Registry in Ghana, Nigeria and Tanzania

2025 · Jack Morrice, Wilson Mupfururirwa, et al. · eJHaem · 10

PDF

The Sickle Cell Disease Ontology: Enabling Collaborative Research and Co-Designing of New Planetary Health Applications

2020 · Victoria Nembaware, Gaston K. Mazandu, et al. · OMICS A Journal of Integrative Biology · 9

Strengthening global partnerships for sustainable sickle cell disease care: insights from SickleInAfrica at the 77th United Nations General Assembly and the US-Africa Leaders’ Summit

2025 · Irene Kida Minja, Siana Nkya, et al. · BMJ Global Health · 6

PDF

Prevalence of Hemoglobin-S and Baseline Level of Knowledge on Sickle Cell Disease Among Pregnant Women Attending Antenatal Clinics in Dar-Es-Salaam, Tanzania

2022 · Hilda J. Tutuba, Agnes Jonathan, et al. · Frontiers in Genetics · 6

PDF

Utilization of Fetal Hemoglobin Parameters in Predicting Clinical Severity of Sickle Cell Disease: Retrospective Study From a Tanzanian Cohort

2025 · Hadiya Haji, Florence Urio, et al. · Journal of Blood Medicine · 4

Clinical depression prevalence and associated factors among adolescents with sickle cell anemia in dar es salaam, tanzania: a cross-sectional study

2025 · Linda Paul Athman, Agnes Jonathan, et al. · BMC Pediatrics · 4

PDF

Oxygen Saturation in Primary Teeth of Individuals With Sickle Cell Disease and Sickle Cell Trait

2022 · Evarist Mulyahela Wilson, Irene Kida Minja, et al. · Journal of Blood Medicine · 4

PDF

Prevalence of Urinary Tract Infections and Antibiogram of Bacteria Isolated From Children With Sickle Cell Disease in Tanzania

2024 · Raphael Z Sangeda, Joseph Yohana, et al. · Cureus · 3

PDF

Dental Caries in Children with Sickle Cell Disease and Its Association with the Use of Hydroxyurea and Penicillin Prophylaxis in Dar Es Salaam

2024 · Irene Minja, Evarist Wilson, et al. · Pediatric Health Medicine and Therapeutics · 3

PDF

Promoting access of hydroxyurea to sickle cell disease individuals: Time to make it an essential medicine

2022 · Manase Kilonzi, Hamu Mlyuka, et al. · F1000Research · 3

Assessment of community knowledge on non-communicable diseases to inform the pilot of WHO PEN-Plus initiatives in selected two districts in Tanzania

2025 · Gibson B. Kagaruki, Peter Mathias Karoli, et al. · PLoS ONE · 2

Effects of Hydroxyurea Treatment on Haemolysis in Patients with Sickle Cell Disease at Muhimbili National Hospital, Tanzania

2021 · Azra Gangji, Upendo , Masamu, et al. · Tanzania Journal of Science · 2

PDF

Newborn Screening for Sickle Cell Disease in Tanzania: The Past, Present and Future

2020 · Fredrick Luoga, Agness Jonathan, et al. · Tanzania Medical Journal · 2

SickleInAfrica Consortium: A Seven-Country Study Evaluating the Performance of Dried Blood Spot Point-of-Care Testing in Newborn Screening for Sickle Cell Disease

2026 · Obiageli Eunice Nnodu, Wilson Mupfururirwa, et al. · Hemoglobin · 1

PDF

Early-life clinical and hematological profiles: a comparative study of children with and without sickle cell disease in the first three years of life

2025 · Siana Nkya, Isihaka Mahawi, et al. · Annals of Hematology · 1

PDF

Level of Healthcare Facility and Psychosocial Factors Influence Perceived Self-Efficacy for Appropriate Use of Hydroxyurea: Experience from Caregivers of Children with Sickle Cell Disease in Tanzania

2025 · Mwashungi Ally, Deodatus Kakoko, et al. · Healthcare · 1

PDF

Caregivers' beliefs about hydroxyurea influence its usage among children with sickle cell disease: a cross-sectional study in Dar-es-Salaam, Tanzania

2025 · Mwashungi Ally, Deodatus Kakoko, et al. · Pan African Medical Journal · 1

Works count: 38

Citation count: 203

H-index: 9

I10-index: 9